Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Poole Sandra, Director. Director active across 1 company, notably Travere Therapeutics, Inc.. In total, 5 reports have been logged. Activity tracked since 14 May 2021. The latest transaction was disclosed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Sandra Poole is a Director at Travere Therapeutics, Inc. She plays a key role in overseeing the company's activities and making strategic decisions. Her experience is valuable for guiding Travere towards sustainable growth and optimal performance.